NNovartis Read More Novartis Bolsters Cancer Portfolio with Major $3 Billion Acquisition2026-03-21 Novartis, Bolsters 21.03.2026 – 05:57:11 | boerse-global.de Novartis acquires PI3K-alpha inhibitor SNV4818 in a…